Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Other Working Capital Changes: 2022-2024

Historic Other Working Capital Changes for Mereo BioPharma Group (MREO) over the last 3 years, with Dec 2024 value amounting to -$3.0 million.

  • Mereo BioPharma Group's Other Working Capital Changes rose 78.39% to -$188,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 720.00%. This contributed to the annual value of -$3.0 million for FY2024, which is 415.57% down from last year.
  • As of FY2024, Mereo BioPharma Group's Other Working Capital Changes stood at -$3.0 million, which was down 415.57% from -$578,000 recorded in FY2023.
  • Over the past 5 years, Mereo BioPharma Group's Other Working Capital Changes peaked at -$578,000 during FY2023, and registered a low of -$3.0 million during FY2024.
  • Over the past 3 years, Mereo BioPharma Group's median Other Working Capital Changes value was -$878,000 (recorded in 2022), while the average stood at -$1.5 million.
  • As far as peak fluctuations go, Mereo BioPharma Group's Other Working Capital Changes spiked by 34.17% in 2023, and later slumped by 415.57% in 2024.
  • Mereo BioPharma Group's Other Working Capital Changes (Yearly) stood at -$878,000 in 2022, then skyrocketed by 34.17% to -$578,000 in 2023, then slumped by 415.57% to -$3.0 million in 2024.